- Home
- / HepaRegeniX
HepaRegeniX
Total Funding
$21.2 M
HepaRegeniX Summary
Company Summary
- Overview
- HepaRegeniX is developing drugs for treating acute and chronic liver diseases. The Company specializes in the discovery and development of small molecule kinase inhibitors.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Tübingen, DE | view all locations
- Website
- http://heparegenix.com/
- Cybersecurity rating
Table of Contents
Key People
Birgit Jung, CSO
LocationsView all
2 locations detected
Tübingen, BW HQ
Germany
Eisenbahnstraße 63
Tübingen, BW
Germany
Wilhelmstraße 16